GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arctic Bioscience AS (OSL:ABS) » Definitions » Cash Flow for Lease Financing

Arctic Bioscience AS (OSL:ABS) Cash Flow for Lease Financing : kr0.00 Mil (TTM As of Dec. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Arctic Bioscience AS Cash Flow for Lease Financing?

Arctic Bioscience AS's Cash Flow for Lease Financing for the six months ended in Dec. 2024 was kr0.00 Mil. Arctic Bioscience AS's Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2024 was kr0.00 Mil.

Compared with last quarter (kr0.00 Mil in Jun. 2024 ), Arctic Bioscience AS's Cash Flow for Lease Financing remained the same in Dec. 2024 (kr0.00 Mil).

Arctic Bioscience AS Cash Flow for Lease Financing Historical Data

The historical data trend for Arctic Bioscience AS's Cash Flow for Lease Financing can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Arctic Bioscience AS Cash Flow for Lease Financing Chart

Arctic Bioscience AS Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Cash Flow for Lease Financing
Get a 7-Day Free Trial - - - - -

Arctic Bioscience AS Semi-Annual Data
Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Cash Flow for Lease Financing Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Arctic Bioscience AS Cash Flow for Lease Financing Calculation

Cash Flow for Lease Financing is change in cash flow resulting from increase or decrease in lease financing.


Cash Flow for Lease Financing for the trailing twelve months (TTM) ended in Dec. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was kr0.00 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Arctic Bioscience AS Cash Flow for Lease Financing Related Terms

Thank you for viewing the detailed overview of Arctic Bioscience AS's Cash Flow for Lease Financing provided by GuruFocus.com. Please click on the following links to see related term pages.

Arctic Bioscience AS Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Arctic Bioscience AS (OSL:ABS) » Definitions » Cash Flow for Lease Financing
Comparable Companies
OSL:BGBIO OSL:PCIB OSL:CRNA OSL:EXTX OSL:SOFTX OSL:ONCIN OSL:ABTEC OSL:ZLNA VRTX ASX:CSL REGN XKRX:207940 ALNY XBRU:ARGX XBRU:UCB ONC XKRX:068270 BNTX SMMT RPRX
Traded in Other Exchanges
9TD:Germany
Address
Industrivegen 42, Orsta, NOR, 6155
Website
https://www.arctic-bioscience.com
Arctic Bioscience AS is a clinical-stage biotechnology company working to develop drug candidates within the areas of autoimmune and inflammatory diseases. It is developing pharmaceutical and commercializing nutraceutical products based on bioactive marine compounds, including lipids essential to maintaining cell membranes. The company's proprietary extraction technology is used to extract membrane fats from marine raw materials, such as herring roe and algae. The company is developing a novel, oral drug candidate (HRO350) for the treatment of mild-to-moderate psoriasis. The company operates geographically in Norway, Americas, Europe, and APAC, with majority of the revenue deriving from Europe.

Arctic Bioscience AS Headlines

No Headlines